Drug combination reduces polyps for patients with high risk for colorectal cancer

In a recent study, researchers randomly assigned 92 patients with familial adenomatous polyposis to the drugs sulindac twice daily and erlotinib daily (n = 46) or placebo (n = 46) for 6 months. The outcome of the study showed very positive results for those with a high risk of colorectal cancer —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail